FEops HEARTguideTM vs CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by FEops nv
VS

AI Verdict

FEops HEARTguide™ specializes in pre-procedural planning for structural heart interventions, using AI for predictive simulations and anatomical insights to optimize device placement. Conversely, the CARTO™ 3 EP Navigation System Software V8.0 is an intra-procedural tool for 3D cardiac mapping and navigation, aiding electrophysiologists in the diagnosis and treatment of heart rhythm disorders. While both are AI-powered cardiology tools, their distinct focus areas in structural heart planning versus electrophysiology mapping make them complementary rather than direct competitors.

Choose FEops HEARTguideTM if…

Choose FEops HEARTguideTM if you need to optimize pre-procedural planning for structural heart interventions like TAVI and LAAO. This platform excels at providing predictive simulations and anatomical insights to guide device sizing and positioning, aiming to improve procedural outcomes before the patient enters the cath lab.

View FEops HEARTguideTM →

Choose CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 if…

Choose CARTO™ 3 EP Navigation System Software V8.0 if your primary need is real-time 3D cardiac mapping and navigation during electrophysiology procedures. It is ideal for diagnosing and treating complex heart rhythm disorders such as AFib and VT, offering advanced features for accurate catheter visualization, rapid anatomical mapping, and enhanced signal analysis for ablation.

View CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature FEops HEARTguideTM CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based On-premise (EP lab system) with optional cloud-based data storage (CARTONET™)
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FEops HEARTguideTM

FEops HEARTguideu2122 is a cloud-based platform, offering access from anywhere at any time, which enhances flexibility and ease of use. Its DICOM interface is designed for easy integration into existing clinical workflows, and it features an intuitive 3-step process for analysis and insights.

Clinical Value

FEops HEARTguideTM

FEops HEARTguideu2122 has demonstrated significant improvements in procedural efficiency and outcomes for structural heart interventions, including a 20% reduction in procedural time and 100% procedural success without major complications in the PREDICT-LAA trial. While CARTOu2122 3 also offers strong clinical benefits in electrophysiology, the quantified impact on patient outcomes and efficiency for FEops HEARTguideu2122 is particularly compelling based on the provided data.

Pricing & Value

Tie

Both tools require direct contact for pricing, and neither publicly discloses their cost structure. This lack of transparency makes it impossible to conduct a head-to-head comparison of their pricing or assess their relative value.

Enterprise Readiness

FEops HEARTguideTM

FEops HEARTguideu2122 is a fully cloud-based platform with a DICOM interface, ensuring seamless integration into existing clinical workflows and offering superior scalability and accessibility for enterprise environments. It also supports collaborative case sharing, further enhancing its readiness for multi-disciplinary or multi-institutional use.

Innovation

FEops HEARTguideTM

FEops HEARTguideu2122 stands out with its unique 'digital twin' technology and predictive simulation for pre-procedural planning, which is described as a paradigm shift in structural heart interventions. This approach of creating patient-specific virtual replicas to test treatment scenarios represents a more fundamentally novel application of AI compared to CARTOu2122 3's enhancements to an established mapping system.

Support & Docs

CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00

CARTOu2122 3, as a product from a large, established medical device company (Biosense Webster, part of Johnson & Johnson MedTech), explicitly mentions a dedicated service and support department and readily available instructions for use. In contrast, specific information regarding support and documentation for FEops HEARTguideu2122 is not provided in the available data.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature FEops HEARTguideTM CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00
Name FEops HEARTguideTM CARTOu2122 3 EP Navigation System Software V8.0 (FG-5400-00
Company FEops nv Biosense Webster, Inc.
Primary Application/Focus Structural heart procedure planning (TAVI, LAAO) providing predictive simulations and anatomical insights. Diagnosis and treatment of heart rhythm disorders (AFib, VT) using 3D cardiac mapping and navigation.
Core Technology Cloud-based AI and digital twin platform for predictive simulations. AI-powered 3D cardiac mapping and navigation system.
Key AI/ML Features Predictive simulation technology for device-anatomy interaction; AI-based anatomical measurements from CT scans. CARTO ELEVATEu2122 Module with machine learning for enhanced signal analysis; CARTOSOUNDu2122 FAM Module utilizing AI/deep-learning for automated 3D left atrial anatomy creation.

Videos

Demos, reviews, and walkthroughs featuring FEops HEARTguideTM and CARTO™ 3 EP Navigation System Software V8.0 (FG-5400-00.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

FEops HEARTguideu2122 is a cloud-based AI and digital twin platform designed for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO. CARTOu2122 3 EP Navigation System Software V8.0 is an FDA-cleared, AI-powered 3D cardiac mapping and navigation system for electrophysiologists, enhancing diagnosis and treatment of heart rhythm disorders such as AFib and VT.
FEops HEARTguideu2122 utilizes AI for predictive simulations of device-anatomy interaction and AI-based anatomical measurements from CT scans. CARTOu2122 3 EP Navigation System Software V8.0 employs AI and machine learning for advanced catheter location, fast anatomical mapping, enhanced signal analysis, automated 3D left atrial anatomy creation, and optimized map creation.
FEops HEARTguideu2122 features a DICOM interface for easy integration into clinical workflows and analyzes cardiac CT scans. CARTOu2122 3 EP Navigation System Software V8.0 offers 'Connection of Choice' for streamlined workflow and automatic catheter recognition, and can import segmented CT or MRI image studies with its CARTOMERGEu2122 Module.
FEops HEARTguideu2122 operates on a service-based business model where clinicians provide input data, FEops prepares the analysis, and then delivers the results, often within one working day. Pricing for the complete CARTOu2122 3 EP Navigation System Software V8.0 is not publicly available and typically requires direct consultation with Biosense Webster sales representatives.
AI Tool Finder
AI-powered search. Results may not be comprehensive.